|
Connect. Collaborate. Contribute.™
|
|
|
COVID-19: From Delta to the Pandemic Endgame
August 11, 2021 | 7:00 pm CDT | Online via Zoom |
|
This event will be virtual
Online via Zoom Speakers Ilya Finkelstein Department of Molecular Biosciences The University of Texas at Austin Jason McLellan Department of Molecular Biosciences The University of Texas at Austin 7:00-8:15pm Conversation |
The COVID-19 pandemic is undergoing a new surge in cases, driven by the increased contagiousness of the Delta variant. As we deal with a third spike in this pandemic, we bring back biologists Ilya Finkelstein and Jason McLellan from The University of Texas to explain what variants are, how they come to be, how we detect them, and more. Ilya and Jason will share what we know about Delta so far, what we can expect, and how we can battle this and future variants. While science and technology play important roles in population health and understanding pandemics, Ilya and Jason will also share what medical and scientific experts believe we can do individually and collectively to improve our outcomes
|
speakERS
|
Ilya Finkelstein is an Associate Professor of Molecular Biosciences at The University of Texas at Austin. Prior to his position at UT-Austin, Dr. Finkelstein received a B.S. from The University of California, Berkeley, a Ph.D. in Chemistry from Stanford University, and completed postdoctoral training at Columbia University Medical Center. Dr. Finkelstein’s lab is investigating the molecular mechanisms of genome maintenance, CRISPR biology, and epigenetic inheritance. In the past year, his group redirected their efforts to studying the SARS-CoV-2 virus with the twin goals of improving next-gen vaccines and creating new therapeutic avenues to end the COVID-19 pandemic.
|
|
Jason McLellan earned a BS in chemistry with an emphasis in biochemistry from Wayne State University in Detroit, Michigan. Afterward, he obtained his PhD from the Johns Hopkins University School of Medicine in Baltimore, Maryland in the laboratory of Dr. Daniel Leahy. He then carried out postdoctoral research at the National Institutes of Health's Vaccine Research Center in the laboratory of Dr. Peter Kwong and in collaboration with Dr. Barney Graham. In the Fall of 2013, he joined the faculty at the Geisel School of Medicine at Dartmouth in the Department of Biochemistry, and in January 2018 he moved his laboratory to The University of Texas at Austin and became a member of the Department of Molecular Biosciences. His lab is interested in elucidating the molecular mechanisms of host–pathogen interactions and leveraging the resulting information for the development of vaccines and immunotherapies.
|
